Compatibility of ketamine and morphine injections

Pain

Volumn 75, Issue 2-3, 1998, Pages 389-390

  Lau, Min Hui ^a   Hackman, Charles ^b   Morgan, Denis J ^a  

^a MONASH UNIVERSITY   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Ketamine; Light susceptibility; Morphine

Indexed keywords

KETAMINE; MORPHINE;

COLOR; DRUG INCOMPATIBILITY; DRUG MIXTURE; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INJECTION; LIGHT EXPOSURE; PH; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0031943311     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(97)00176-0     Document Type: Article

References (6)

1. Bristow A., Orlikowski C. Subcutaneous ketamine analgesia: postoperative analgesia using subcutaneous infusions of ketamine and morphine. Ann. R. Coll. Surg. Eng. 71:1989;64-66.
2. Christie J.M., Jones C.W., Markowsky S.J. Chemical compatibility of regional anesthetic drug combinations. Ann. Pharmacother. 26:1992;1078-1080.
3. Clark J.L., Kalan G.E. Effective treatment of severe cancer pain of the head using low-dose ketamine in an opioid-tolerant patient. J. Pain Symptom Manage. 10:1995;310-314.
4. Eide K., Stubhaug A., Oye I., Breivik H. Continuous subcutaneous administration of the N-methyl-D-aspartic acid (NMDA) receptor antagonist ketamine in the treatment of post-herpetic neuralgia. Pain. 61:1995;221-228.
5. Glare P.A., Walsh T.D., Pippenger C.E. A simple, rapid method for the simultaneous determination of morphine and its principal metabolites in plasma using high-performance liquid chromatography and fluorimetric detection. Ther. Drug Monit. 13:1991;226-232.
6. Mercadante S., Lodi F., Sapio M., Calligara M., Serretta R. Long-term ketamine subcutaneous continuous infusion in neuropathic cancer pain. J. Pain Symptom Manage. 10:1995;564-568.